Publications

Metabolic Dysregulation Explains the Diverse Impacts of Obesity in Males and Females with Gastrointestinal Cancers. Spencer R. Rosario, Bowen Dong, et al.

Exploiting Convergent Phenotypes to Derive a Pan-cancer Cisplatin Response Gene Expression Signature. Scarborough JA, Eschrich SA, et al.

A bioinformatics tool for identifying intratumoral microbes from the ORIEN dataset. Cankun Wang, Anjun Ma, et al.

The tumor microbiome as a predictor of outcomes in patients with metastatic melanoma treated with immune checkpoint inhibitors. Caroline E. Wheeler, Samuel S. Coleman IV, et al.

Pan-cancer Landscape of Programmed Death Ligand-1 and Programmed Death Ligand-2 Structural Variations. Hoskins EL, Samorodnitsky E, et al.

Replicative Instability Drives Cancer Progression. Morris BB, Smith JP, Zhang Q, et al.

Factors Predicting Participation in the Prospective Genomic Sequencing Study, Total Cancer Care (TCC), in Kentucky. Riggs MJ, Huang B, Chen Q, et al.

Systematic evaluation of the predictive gene expression signatures of immune checkpoint inhibitors in metastatic melanoma. Coleman S, Xie M, Tarhini AA, et al.

Racial and ethnic differences in clonal hematopoiesis, tumor markers, and outcomes of patients with multiple myeloma. Peres LC, Colin-Leitzinger CM, Teng M, et al.

Therapeutic Targeting of Protein Disulfide Isomerase PDIA1 in Multiple Myeloma. Hasipek M, Grabowski D, Guan Y, et al.